RL
PFE icon

Rogco LP’s Pfizer PFE Stock Holding History

Rogco LP’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Buy
19,940
+1,564
+9% +$40.9K 0.15% 89
2026
Q1 		$516K Buy
18,376
+125
+0.7% +$3.33K 0.17% 84
2025
Q4 		$454K Sell
18,251
-143
-0.8% -$3.61K 0.15% 88
2025
Q3 		$469K Sell
18,394
-1,421
-7% -$35.1K 0.16% 84
2025
Q2 		$480K Buy
19,815
+539
+3% +$12.6K 0.18% 84
2025
Q1 		$488K Buy
19,276
+2,688
+16% +$70.3K 0.2% 78
2024
Q4 		$440K Sell
16,588
-2,241
-12% -$60.8K 0.18% 82
2024
Q3 		$545K Sell
18,829
-965
-5% -$28.1K 0.21% 76
2024
Q2 		$554K Sell
19,794
-290
-1% -$7.98K 0.23% 71
2024
Q1 		$557K Sell
20,084
-1,989
-9% -$55.2K 0.23% 71
2023
Q4 		$635K Sell
22,073
-30
-0.1% -$907 0.28% 59
2023
Q3 		$733K Buy
+22,103
New +$782K 0.36% 46

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rogco LP's PFE Position: Q2 2026 in Review

Rogco LP increased its Pfizer (PFE) stake by 8.5% in Q2 2026, buying an estimated $40.9K and bringing the position to 19,940 shares worth $480K. The position accounts for 0.15% of the portfolio, ranked #89.

Rogco LP first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $733K in Q3 2023. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Rogco LP held 19,940 shares of Pfizer worth $480K as of Q2 2026.
  • Rogco LP bought 1,564 Pfizer shares in Q2 2026, an estimated $40.9K.
  • Pfizer made up 0.15% of Rogco LP's portfolio in Q2 2026, its #89 holding.
  • Rogco LP first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Rogco LP's Pfizer position peaked at $733K in Q3 2023.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Rogco LP's 13F filing for Q2 2026, filed 30 Jul 2026.